Trial Profile
Circadian variations in cytokines and the effect of timed release tablet prednisone in rheumatoid arthritis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Sep 2021
Price :
$35
*
At a glance
- Drugs Prednisone (Primary)
- Indications Rheumatoid arthritis
- Focus Pharmacodynamics
- 19 Jan 2012 Actual end date (Jun 2008) added as reported by ISRCTN: Current Controlled Trials.
- 19 Jan 2012 Status changed from active, no longer recruiting to completed as reported by ISRCTN: Current Controlled Trials.
- 22 Nov 2006 New trial record.